HLN
Price
$10.38
Change
+$0.36 (+3.59%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
44.06B
7 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$16.38
Change
+$0.47 (+2.95%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
2.21B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HLN vs PRGO

HLN vs PRGO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HLN vs. PRGO commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a StrongBuy and PRGO is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HLN with price predictions
Oct 22, 2026

Momentum Indicator for HLN turns positive, indicating new upward trend

HLN saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 72 similar instances where the indicator turned positive. In 45 of the 72 cases, the stock moved higher in the following days. The odds of a move higher are at 62%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for HLN just turned positive on October 08, 2026. Looking at past instances where HLN's MACD turned positive, the stock continued to rise in 21 of 35 cases over the following month. The odds of a continued upward trend are 60%.

HLN moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HLN crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 40%.

Following a +0.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where HLN advanced for three days, in 138 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for HLN moved below the 200-day moving average on September 21, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

HLN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HLN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. HLN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.690) is normal, around the industry mean (10.407). P/E Ratio (27.377) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (2.158) is also within normal values, averaging (2.152). Dividend Yield (0.025) settles around the average of (0.037) among similar stocks. P/S Ratio (2.739) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for PRGO with price predictions
Oct 22, 2026

Momentum Indicator for PRGO turns positive, indicating new upward trend

PRGO saw its Momentum Indicator move above the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In 58 of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PRGO just turned positive on October 12, 2026. Looking at past instances where PRGO's MACD turned positive, the stock continued to rise in 24 of 40 cases over the following month. The odds of a continued upward trend are 60%.

Following a +4.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRGO advanced for three days, in 179 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

The Aroon Indicator entered an Uptrend today. In 120 of 204 cases where PRGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The 10-day RSI Indicator for PRGO moved out of overbought territory on October 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 25 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

PRGO broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.878) is normal, around the industry mean (10.407). P/E Ratio (-1.271) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (1.142) is also within normal values, averaging (2.152). Dividend Yield (0.073) settles around the average of (0.037) among similar stocks. P/S Ratio (0.454) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. PRGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
PRGO: Fundamental Ratings
PRGO
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNPRGO
RSI
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
60%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 7 days ago
64%
Declines
ODDS (%)
Bearish Trend 22 days ago
51%
Bearish Trend 22 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 1 day ago
63%
Aroon
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
59%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (HLN: $10.02 vs. PRGO: $15.91)
Brand notoriety: HLN and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLN: 78% vs. PRGO: 87%
Market capitalization -- HLN: $44.06B vs. PRGO: $2.21B
HLN [@Pharmaceuticals: Generic] is valued at $44.06B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.21B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 1 FA rating(s) are green while PRGO’s FA Score has 1 green FA rating(s).

  • HLN’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, HLN is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 5 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • HLN’s TA Score: 5 bullish, 6 bearish.
  • PRGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HLN is a better buy in the short-term than PRGO.

Price Growth

HLN (@Pharmaceuticals: Generic) experienced а +3.51% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.

Reported Earning Dates

HLN is expected to report earnings on Oct 29, 2026.

PRGO is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-2.94% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
HLN
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with TAK. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
+3.49%
TAK - HLN
46%
Loosely correlated
+2.16%
PBH - HLN
38%
Loosely correlated
+3.21%
ZTS - HLN
35%
Loosely correlated
+2.99%
PRGO - HLN
29%
Poorly correlated
+2.89%
LFCR - HLN
27%
Poorly correlated
N/A
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+2.89%
SUPN - PRGO
49%
Loosely correlated
+2.09%
ELAN - PRGO
37%
Loosely correlated
+0.62%
EVO - PRGO
35%
Loosely correlated
-1.28%
PBH - PRGO
35%
Loosely correlated
+3.21%
ALVO - PRGO
34%
Loosely correlated
-6.63%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ABND42.210.32
+0.76%
American Century Core Plus Income ETF (ABND)
HFSI33.850.21
+0.62%
Hartford Strategic Income ETF (HFSI)
GLV5.69-0.02
-0.35%
Clough Global Dividend and Income Fund
ETNG9.90-1.44
-12.71%
Leverage Shares 2X Long ETN Daily ETF (ETNG)
VSTL19.66-4.96
-20.15%
Defiance Daily Target 2X Long VST ETF (VSTL)